MENU
+Compare
PRPH
Stock ticker: NASDAQ
AS OF
Dec 24, 02:00 PM (EDT)
Price
$0.61
Change
-$0.07 (-10.14%)
Capitalization
2.88M

PRPH ProPhase Labs Inc. Forecast, Technical & Fundamental Analysis

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more

PRPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PRPH with price predictions
Dec 23, 2025

PRPH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for PRPH turned positive on December 09, 2025. Looking at past instances where PRPH's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PRPH advanced for three days, in of 264 cases, the price rose further within the following month. The odds of a continued upward trend are .

PRPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for PRPH moved below the 200-day moving average on December 02, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PRPH entered a downward trend on December 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.419) is normal, around the industry mean (12.631). P/E Ratio (0.000) is within average values for comparable stocks, (131.198). PRPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). PRPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.017). P/S Ratio (0.490) is also within normal values, averaging (11.789).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. PRPH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
PRPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PRPH is expected to report earnings to fall 25.00% to -11 cents per share on April 01

ProPhase Labs Inc. PRPH Stock Earnings Reports
Q4'25
Est.
$-0.12
Q3'25
Missed
by $0.05
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
The last earnings report on November 19 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 570.71K shares outstanding, the current market capitalization sits at 2.88M.
A.I.Advisor
published Dividends

PRPH paid dividends on June 03, 2022

ProPhase Labs Inc. PRPH Stock Dividends
А quarterly dividend of $0.30 per share was paid with a record date of June 03, 2022, and an ex-dividend date of May 24, 2022. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of cold remedy products and other supplements

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Household Or Personal Care
Address
711 Stewart Avenue
Phone
+1 215 345-0919
Employees
113
Web
https://www.prophaselabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVH4.160.14
+3.48%
Evolent Health
OHI43.860.25
+0.57%
Omega Healthcare Investors
BANR65.24-0.63
-0.96%
Banner Corp
KORE4.36-0.09
-2.02%
KORE Group Holdings
IMTE0.65-0.02
-3.42%
Integrated Media Technology Limited

PRPH and Stocks

Correlation & Price change

A.I.dvisor tells us that PRPH and ANIP have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRPH and ANIP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRPH
1D Price
Change %
PRPH100%
-29.18%
ANIP - PRPH
28%
Poorly correlated
+0.01%
ICCM - PRPH
27%
Poorly correlated
+0.72%
NVST - PRPH
27%
Poorly correlated
-2.54%
MTD - PRPH
24%
Poorly correlated
+0.16%
ISPC - PRPH
24%
Poorly correlated
+2.26%
More